Cannabis Has Been Studied More Than Many FDA Approved Pharmaceuticals

By | February 2nd, 2015|Categories: FDA|

Opponents of legalizing cannabis for medicinal purposes are fond of arguing that the plant must be subjected to the same standards of clinical study and FDA review as conventional medicines. What they fail to mention is that cannabis and its active components have already been subjected to a greater degree of scientific scrutiny than many [...]